Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported Outcomes

Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported Outcomes

Raisa Epistola,1 Rubens Sperandio,2 Zev Wainberg,3 Syma Iqbal,4 Joseph Chao5 1Department of Internal Medicine, Division of Hematology and Medical Oncology, Harbor UCLA Medical Center, Torrance, CA, USA; 2Centro de Oncologia e Hematologia Einstein Família Dayan-Daycoval, Hospital Israelita Albert Ein...

Full description

Bibliographic Details
Main Authors: Epistola R, Sperandio R, Wainberg Z, Iqbal S, Chao J
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Cancer Management and Research
Subjects:
immunotherapy
immune checkpoint inhibition
pd-l1
gastric cancer
gastroesophageal junction cancer
Online Access:https://www.dovepress.com/role-of-pd-1-inhibitors-in-the-treatment-of-esophagogastric-adenocarci-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/role-of-pd-1-inhibitors-in-the-treatment-of-esophagogastric-adenocarci-peer-reviewed-fulltext-article-CMAR

Similar Items